Staphylococcus aureus vaccine composition
The present invention relates to an immunogenic composition for inducing an immune response in a subject to treat and/or prevent Staphylococcus aureus infection. Immunogenic compositions disclosed herein comprise a Staphylococcus aureus protein A (SpA) polypeptide and a Staphylococcus aureus leukoci...
Saved in:
Main Authors | , , , , , , , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
05.01.2024
|
Subjects | |
Online Access | Get full text |
Cover
Summary: | The present invention relates to an immunogenic composition for inducing an immune response in a subject to treat and/or prevent Staphylococcus aureus infection. Immunogenic compositions disclosed herein comprise a Staphylococcus aureus protein A (SpA) polypeptide and a Staphylococcus aureus leukocidin A (LukA) and/or leukocidin B (LukB) variant polypeptide. The invention also relates to methods of generating an immune response against Staphylococcus aureus in a subject involving administering the disclosed immunogenic compositions.
本发明涉及用于诱导对象免疫应答以治疗和/或预防金黄色葡萄球菌感染的免疫原性组合物。本文公开的免疫原性组合物包含金黄色葡萄球菌蛋白A(SpA)多肽和金黄色葡萄球菌杀白细胞素A(LukA)和/或杀白细胞素B(LukB)变体多肽。本发明还涉及在对象中产生针对金黄色葡萄球菌的免疫应答的方法,其涉及施用所公开的免疫原性组合物。 |
---|---|
Bibliography: | Application Number: CN202280034397 |